In rodent models of PAH, recombinant human ACE2 has been shown to treat established PAH, including bone morphogenetic protein receptor type II mutation‐related PAH17 and pulmonary artery banding models.18 The gene discussed is ACE2; the disease is pulmonary arterial hypertension.